This AI stock is up over 100% in pre-market

Today's Market Movers 🕺                                                                                                                                                                                                                                                                                                                                                                                                                 February 14, 2023 Good day, 360 – Here are our top 3 trade ideas today – these setups look primed! Be the best prepared trader on the Street! AMST - Explodes over 100% in pre-market after announcing it was leveraging ChatGPT engine for its learning platform WISH - 2nd day play, closed 37% higher after Citron Research makes bullish tweet PLTR - 16% higher in after hours after earnings beat A message from [Masterworks](* $17.7 Billion Year Highlights Safe Haven Asset For 2023, investors have one New Year's resolution: Stop. Losing. Money. From “transitory” inflation, to millennial Bernie Madoff, 2022 was a wild ride in the markets. That is, except for one market. The blue-chip art market. In fact, art auctions hauled in nearly $18 billion in 2022. The best year ever in a 277-year old market – all while financial markets tanked. Now you’re probably wondering: “That's great, but how can someone like me get in on the action?” The answer is easily, with [Masterworks](. Masterworks securitizes artworks by qualifying offerings with the SEC, allowing YOU to invest in shares of multi-million dollar paintings by names like Banksy. Masterworks has also built a solid track record with all 9 of their exits netting a profit, the last 3 realizing +13.9%, +17.8%, and +21.5% net returns each. 360 Wall St. readers can skip the waitlist to join [HERE](. See important Regulation A disclosures by clicking this [link](. AMST - Explodes over 100% in pre-market after announcing it was leveraging ChatGPT engine for its learning platform Amesite (AMST), an AI software company for business and education, announced it would expand its platform capabilities to include GPT-3, the engine for ChatGPT on its learning platform to complement its existing AI capabilities. Given the current market euphoria regarding ChatGPT and AI companies, that was enough to send the stock over 120% higher. According to Finviz, as of yesterday’s close, AMST had a gloat of 20.82M shares and a market cap of $10.37M. The pre-market high was $0.70 for AMST and was where the stock found resistance initially. Above $0.70, the next major targets are $0.80, $0.90 then $1. The next targets to the upside are $1.32, $1.40 and $1.60. Below $0.70 there is potential support at $0.53-$0.55, $0.45, $0.4 and a gap fill at $0.2807. WISH - 2nd day play, closed 37% higher after Citron Research makes bullish tweet Citron Research, a renowned analyst firm run by Andrew Left, with a huge following [Tweeted]( yesterday: We were reluctant to mention $WISH until we saw the Super Bowl. The $Wish business model seemed terminal....and then everything changed!!! It has now become the most assymetrical opportunity in the market. A series of analysis followed and a promise to release a research report on the company. This catalyst saw an influx of volume into WISH and a significant move higher. Remember WISH was a meme stock from 2021 that used to trade above $10. Yesterday’s high of $1.07 should be an important pivot level today. Above it, targets to the upside are $1.20, $1.38, $1.60 then $1.80 and $2.05. Below $1.07 there is potential support at the $0.83-$0.86 area with $0.77-$0.78 and $0.64 targets below that. PLTR - 16% higher in after hours after earnings beat Palantir (PLTR) reported Q4 EPS of $0.04 vs $0.03 estimate with sales of $508.62M beating the $502.25M estimate. The sales figure was a 17.5% increase over last year's sales of $432.57M for the same period. This earnings number turned PLTR to profitability, a milestone for the company and investors wary of money-losing growth stocks. CEO Alex Karp also touted their artificial intelligence advantage. The after-hours high of $9.36 would be the first target for the bulls. Above that, there is a gap to fill at $9.74 and $10 is a major psychological target. The next major resistance levels higher are at $10.30, $10.50, $11 and $11.50. To the downside, there is potential support at $8.71, $8.50, $8 and a gap to fill at $7.61 Economic Calendar (EST) 6:00 am NFIB Small business optimism index 8:30am CPI 8:55am Redbook sales 11:00am Fed speak Lorie Logan 11:00am 4- and 8-week bill announcements 2:05pm Fed speaker John Williams 4:30pm API Crude oil data Earnings for Today (After Market) ABNB, ADC, ADPT, AKAM, AKR, ANDE, AYTU, BL, CETX, CHCT, CIDM, CLW, CNDT, CPSI, CRK, DAC, DVN,EGAN, EHAB, ELMD, ENLC, GDDY, GXO, HLF, ILPT, IPW, ISSC, IVT, LAB, LTHM, MCY, MGY, NMIH, NMTC,NRC, NRDS, NU, OSUR, PCYG, POWW, PRST, PYX, SB, SCI, SMWB, TGAN, TRIP, TX, UDMY, UPST, UPXI, VINP,VPG, VRAR, WIRE Top Headlines ALSN Allison Specialty Series™ Transmissions Selected for the U.S. Army’s Common Tactical Truck Prototype Vehicles TSLA Soros Fund Management Raises Share Stake In Tesla Inc By 47.3% To 132,046 Shares BTAI BioXcel Therapeutics Announces Positive Full Data from Phase 2 Trial of BXCL701 in Rare, Aggressive Form of Prostate Cancer; to be Presented at 2023 ASCO Genitourinary Cancers Symposium SGEN Seagen to Highlight Research in Urothelial Cancer at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium ARAV Aravive to Present Positive Updated Data from Phase 1b Trial of Batiraxcept in Combination with Cabozantinib for Treatment of Clear Cell Renal Cell Carcinoma at the 2023 ASCO Genitourinary (GU) Cancers Symposium EXEL BMY Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Shows Durable Survival with Over Three Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma EPIX ESSA Pharma Announces Presentations at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) MGNX: MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium VCYT New Data To Be Presented at 2023 ASCO GU Suggest Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment GSRM GSR II Meteora Acquisition Corp. Announces Update on Proxy Statement for Proposed Business Combination with Bitcoin Depot WMT Walmart to Close Three Tech Hubs, Tells Tech Staff to Return to Offices -- WSJ *Walmart to Close Tech Offices in Austin, Portland and Carlsbad, Cali Staff May Relocate to Other Offices or Leave With Severance *Walmart Tells Tech Staff to Work From Office Twice Per Week CGEM Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed license fee $25m. BB Chongqing Yazaki Selects BlackBerry to Power Digital LCD Cluster for the Chinese Market KD NOK Kyndryl and Nokia Expand Global Network and Edge Computing Alliance WKEY WISeKey Announces the Development of WISe.Social, a New Authenticated Social Media Network Powered by WISeID AKAM Akamai Unveils Akamai Connected Cloud and New Cloud Computing Services TSLA TESLA WORKERS LAUNCH UNION CAMPAIGN IN NEW YORK – BLOOMBERG LMND BNP Paribas Cardif and Lemonade to offer 100% online renters’ insurance F Ford to cut 3,800 engineering, administration jobs in Europe TSLA Tesla cuts the price of the standard Model 3 in the US by $500 to $42,990, while performance remains unchanged. Tesla yesterday increased the price of the Model Y AWD (Standard Range) by $500 for the second time in 2 days. BA Boeing Trims India Forecast to 2,210 New Jets Over Next 20 Years - Economic Times COHR Coherent Introduces 2x1000 mW Dual-Chip Pump Laser Module for Optical Amplification in Optical Networks MAXR Maxar Secures Dedicated Access to Umbra’s SAR Constellation, Creating the Geospatial Industry’s Most Advanced Multisource Intelligence Solution ROC Drilling Tools International, a Leading Oilfield Services Company, to List on Nasdaq through Business Combination with ROC Energy Acquisition Corp. AULT: Ault Alliance Announces Update on Dividend of Shares of TurnOnGreen and Giga-tronics to Its Stockholders NETC: Vast, a Market-Leading Concentrated Solar Power (CSP) Company, to go Public Through Business Combination with Nabors Energy Transition Corp.; Combined Company Expected to be Listed on the New York Stock Exchange IGT: IGT Deploys World-Class Retail and Mobile PlaySports™ Technology at Treasure Bay Casino and Hotel in Mississippi ASXC Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery GRTS Gritstone bio and the National Cancer Institute (NCI) Establish a Clinical Trial Agreement to Evaluate a Neoantigen Cell Therapy-Vaccine Combination BCYC: 50% overall response rate (ORR) and 75% clinical benefit rate, including one complete response in urothelial cancer at the 5 mg/m2 dose on an intent-to-treat (ITT) basis as of January 2023, median duration of response (mDOR) is estimated to be approximately 14 months among urothelial cancer patients in the 5 mg/m2 cohort confirmed RECIST responses in non-small cell lung cancer (NSCLC) and breast cancer patients SDGR Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda CGEN: Rilvegostomig, AstraZeneca's Bi-specific Antibody Derived from Compugen's COM902, Expected to Progress into Phase 3 MNPR: Monopar Announces Camsirubicin Clinical Program Update - Improved Side Effect Profile Seen to Date Compared to Doxorubicin To Your Success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions DISCLAIMER: To more fully understand RagingBull.com, LLC’s issuer-paid advertisement disclaimer and disclosure policy located at [(. *ISSUER-PAID AD. RagingBull expects to receive around $1000 in compensation. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Raging Bull nor any of its owners, employees OR INDEPENDENT CONTRACTORS is CURRENTLY registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements.In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 lee, NH 03861, United States [Publish on Beehiiv](